​
Login / Signup
Alexandria Matic
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 5
Top Topics
Double Blind
Clinical Trial
Myasthenia Gravis
Phase Ii
Top Venues
Expert opinion on biological therapy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Alexandria Matic
,
Nouf Alfaidi
,
Vera Bril
An evaluation of rozanolixizumab-noli for the treatment of anti-AChR and anti-MuSK antibody-positive generalized myasthenia gravis.
Expert opinion on biological therapy
(2023)
Alexandria Matic
,
Nouf Alfaidi
,
Vera Bril
An evaluation of rozanolixizumab-noli for the treatment of anti-AChR and anti-MuSK antibody-positive generalized myasthenia gravis.
Expert opinion on biological therapy
23 (12) (2023)
Alexandria Matic
,
Nouf Alfaidi
,
Vera Bril
An evaluation of rozanolixizumab-noli for the treatment of anti-AChR and anti-MuSK antibody-positive generalized myasthenia gravis.
Expert opinion on biological therapy
(2023)
Alexandria Matic
,
Nouf Alfaidi
,
Vera Bril
An evaluation of rozanolixizumab-noli for the treatment of anti-AChR and anti-MuSK antibody-positive generalized myasthenia gravis.
Expert opinion on biological therapy
23 (12) (2023)
Alexandria Matic
,
Nouf Alfaidi
,
Vera Bril
An evaluation of rozanolixizumab-noli for the treatment of anti-AChR and anti-MuSK antibody-positive generalized myasthenia gravis.
Expert opinion on biological therapy
23 (12) (2023)